
Prof Martin Kaiser
doctorMale0.0Global Dominance: 0.00%
Prof Martin Kaiser is a leading researcher in myeloma molecular therapy at the Institute of Cancer Research, advocating for the innovative 'Trojan horse' therapy and asserting that it represents a critical advancement towards achieving long-term remission for myeloma patients.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Prof Martin Kaiser, team leader in myeloma molecular therapy at the Institute of Cancer Research, said these 'are very smart drugs'.
World-first 'Trojan horse' therapy to be given on NHSBBC·
United Kingdom· 2025-06-13



